dabigatran has been researched along with Cranial Sinus Thrombosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Papuga-Szela, E; Rusin, G; Undas, A; Wypasek, E; Żuk, J | 1 |
Bendszus, M; Caria, J; Coutinho, JM; Dentali, F; Diener, HC; Ferro, JM; Huisman, H; Jansen, O; Kobayashi, A; Miede, C; van der Veen, B | 1 |
Chiu, D; Weinberger, J | 1 |
Aguiar de Sousa, D; Bendszus, M; Caria, J; Coutinho, JM; Dentali, F; Diener, HC; Ferro, JM; Huisman, H; Jansen, O; Kobayashi, A; Miede, C; Neto, LL | 1 |
Hu, Y; Tang, Z; Xu, S; Zhu, W | 1 |
1 trial(s) available for dabigatran and Cranial Sinus Thrombosis
Article | Year |
---|---|
Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis.
Topics: Anticoagulants; Cerebral Veins; Dabigatran; Humans; Prospective Studies; Sinus Thrombosis, Intracranial; Stroke; Treatment Outcome; Venous Thrombosis; Warfarin | 2022 |
4 other study(ies) available for dabigatran and Cranial Sinus Thrombosis
Article | Year |
---|---|
Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution's experience.
Topics: Administration, Oral; Adult; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Rivaroxaban; Sinus Thrombosis, Intracranial | 2019 |
Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis.
Topics: Adult; Anticoagulants; Antithrombins; Arteriovenous Fistula; Central Nervous System Vascular Malformations; Cerebral Angiography; Cerebral Veins; Cranial Sinuses; Dabigatran; Female; Humans; Imaging, Three-Dimensional; Intracranial Thrombosis; Magnetic Resonance Angiography; Male; Meningeal Arteries; Middle Aged; Randomized Controlled Trials as Topic; Secondary Prevention; Sinus Thrombosis, Intracranial; Venous Thrombosis; Warfarin | 2020 |
Cerebral Venous Sinus Thrombosis and Acute Myocardial Infarction in a Patient with PAI-1 4G/4G Homozygosity.
Topics: Adult; Anticoagulants; Antithrombins; Dabigatran; Drug Substitution; Genetic Predisposition to Disease; Hemostasis; Heparin; Homozygote; Humans; Male; Myocardial Infarction; Phenotype; Plasminogen Activator Inhibitor 1; Sinus Thrombosis, Intracranial; Time Factors; Treatment Failure; Warfarin | 2020 |
Clinical Reasoning: A teenager with persistent headache.
Topics: Adolescent; Anticoagulants; Blood Proteins; Brain; Dabigatran; Diuretics, Osmotic; Frameshift Mutation; Headache; Heparin, Low-Molecular-Weight; Humans; Intracranial Hypertension; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Phlebography; Protein S; Protein S Deficiency; Sinus Thrombosis, Intracranial | 2019 |